Cetera Investment Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.2K | Sell |
18,150
-4,652
| -20% | -$18K | ﹤0.01% | 3932 |
|
|
2025
Q1 | $114K | Buy |
22,802
+8,449
| +59% | +$42.2K | ﹤0.01% | 3746 |
|
|
2024
Q4 | $103K | Buy |
14,353
+1,270
| +10% | +$9.16K | ﹤0.01% | 3570 |
|
|
2024
Q3 | $80.3K | Buy |
13,083
+51
| +0.4% | +$313 | ﹤0.01% | 3563 |
|
|
2024
Q2 | $86.7K | Sell |
13,032
-52,304
| -80% | -$348K | ﹤0.01% | 3534 |
|
|
2024
Q1 | $665K | Buy |
+65,336
| New | +$665K | ﹤0.01% | 2387 |
|